Latest News
AT&T Stock Rebounds After $23B Spectrum Deal, Debt Concerns Loom
AT&T shares rebounded 0.7% to $23.38 after a two-day slide, following its $23B spectrum acquisition from EchoStar. The deal adds $14.5B in short-term debt, with leverage expected to peak at 3.2x.
Mangoceuticals Rockets 173% on Nuclear Merger; Existing Holders Left with 4%
Mangoceuticals (MGRX) shares soared 173.5% to $0.8029 after announcing a reverse merger with Nuclea Energy, with existing shareholders retaining only 4% pre-PIPE.
Focus Universal Stock Rockets 651% on AI Debut, But Skeptics Abound
Focus Universal (FCUV) soared 651% after unveiling an AI document platform, but the move is driven by speculation rather than fundamentals, with no revenue details disclosed.
TELUS Dividend Cut Triggers 12% Stock Drop, Yield Parity with BCE
TELUS shares tumbled 12.3% to C$13.22 after cutting its dividend by 55%, bringing its yield to 5.7% near BCE's 5.8%. The company also lowered free cash flow guidance by 27%.
Tesla Stock Retreats as Shanghai Export Reliance Raises Investor Concerns
Tesla shares gave up early gains after Elon Musk dismissed a report about splitting China operations, but concerns over Shanghai's export dependence and margin pressures persist.
Coinbase Stock Tumbles 14% as Q3 Revenue Outlook Weakens
Coinbase shares plunged 14% as Q2 results missed estimates and Q3 core revenue projections fell 13%, raising concerns about cost structure and margins.
Novo Nordisk Shares Plunge 9% as ZEUS Trial Fails to Show Cardiovascular Benefit
Novo Nordisk shares fell sharply after ZEUS trial data showed no significant cardiovascular benefit, wiping out $20.5 billion in market cap and underscoring heavy reliance on GLP-1 franchise.
Rivian Stock Slips Despite Q2 Beat as Vehicle Margins Remain a Concern
Rivian shares dropped 4.3% after Q2 results beat estimates but revealed automotive gross losses, with software and credits propping up profitability.
Western Union stock slides 11% as digital shift erodes per-transaction revenue
Western Union shares fell 11% after Q2 earnings missed estimates and full-year guidance was slashed, as digital transaction growth weighed on per-transaction revenue and margins.
Newell Brands Stock Soars 25% on First Sales Growth in Four Years
Newell Brands (NWL) surged 25% after posting its first core sales growth in over four years and receiving $126 million in tariff refunds, prompting a raised full-year forecast.
Replimune Rockets 131% on FDA Panel Backing for RP1
Replimune shares jumped 131% to $12.50 after an FDA panel voted 10-3 that RP1's efficacy data is interpretable and clinically important, adding nearly $600 million in market value.